Foundayo is the new once-a-day weight loss tablet that has just arrived in the UK, and it does something no treatment before it managed: it delivers a GLP-1 medicine as a simple pill with no fasting, no water rules, and no fixed time of day. For a lot of people, that is the difference between a treatment that fits their life and one that does not.
If you are weighing up Foundayo in Swansea, this guide covers what it is, how it works, how it compares to the injections and the Wegovy pill, who it suits, what it costs, and how to get it at Medihub, with a real prescriber to talk it through rather than a form on a website.
Why Medihub?
Foundayo is brand new, which is exactly when a face-to-face prescriber matters most. At Medihub you are seen in person by a GPhC-registered Independent Prescriber at our Killay or Pontarddulais branch, with a proper assessment, ongoing monitoring, and someone local to answer your questions. No GP referral needed.
What Is Foundayo?
Foundayo is Eli Lilly’s brand name for orforglipron, a once-daily weight loss tablet. It belongs to the same family of medicines as Mounjaro and Wegovy, the GLP-1 receptor agonists, which work with your body’s own appetite signals to reduce hunger and help you eat less. The headline difference is the form: Foundayo is a tablet, taken once a day.
It was approved by the UK medicines regulator, the MHRA, on 10 August 2026, making the UK the first country in Europe to license it, for both weight management and type 2 diabetes. Private pharmacy supply began in late August 2026, so this genuinely is a new treatment rather than one that has been around for years.
How Foundayo Is Different from the Injections and the Wegovy Pill
There are already two ways to take semaglutide-style treatment: a weekly injection (Mounjaro and Wegovy) or, more recently, the Wegovy pill. Foundayo is different from all of them in one important, practical way.
Foundayo is a non-peptide, small-molecule tablet. In plain terms, that means it survives stomach acid intact, so it does not need the fasting window, the sip-of-water-only rule, or the wait-before-eating routine that the Wegovy pill requires. You take it once a day, at any time of day, with or without food. It also, of course, avoids needles altogether. That flexibility is the single biggest reason people are interested in it. If you want a full side-by-side of all three options, see our guide to comparing weight loss treatments.
The practical difference
A daily tablet, any time of day, with or without food or water. No injection, and none of the fasting or water rules that the Wegovy pill needs. For shift workers, frequent travellers, or anyone who never got on with a fixed routine, that matters.
How Well Does Foundayo Work?
Foundayo was approved on the back of a large clinical trial programme. In its main weight-management trial (ATTAIN-1), the highest dose produced an average weight loss of more than 11% of body weight over 72 weeks, compared with under 1% for placebo, alongside improvements in waist circumference, cholesterol, triglycerides and blood pressure. As with any treatment, results vary from person to person and depend on your starting point, your dose, and the diet and activity changes you make alongside it.
ATTAIN-1 Clinical Trial (highest dose)
Over 11%
average body weight loss over 72 weeks
Highest-dose group versus under 1% on placebo, alongside a reduced-calorie diet and increased activity. Individual results vary. Source: ATTAIN-1 trial (Eli Lilly).
Your prescriber will give you a realistic picture for your situation at your consultation, rather than a headline number.
Who Foundayo Is For
Foundayo is licensed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related health condition such as high blood pressure, prediabetes, high cholesterol, obstructive sleep apnoea or cardiovascular disease. It is used together with a reduced-calorie diet and increased physical activity, not on its own. It is also licensed to help control blood sugar in type 2 diabetes, which is a separate consideration your prescriber can discuss.
A full assessment at your first appointment establishes whether it is suitable and right for you. That assessment is the whole point of a face-to-face service, and it is why we see every patient in person.
Foundayo and the NHS
Foundayo is not currently available on the NHS. NICE, the body that decides which treatments the NHS funds, is due to give its decision on 18 November 2026. Even a positive decision would most likely mean phased, restricted access starting sometime in 2027, which is the same pattern Mounjaro followed. For now, if you want to start Foundayo, the route is a private prescription, and that is what we provide at Medihub.
Foundayo Prices at Medihub
Foundayo is titrated, which means you start on a low dose and build up gradually. Our prices for each dose are below. Every price includes a monthly face-to-face consultation, a blood pressure check and a weight check, so the medicine comes with proper clinical care rather than being posted out on its own.
You will find Foundayo cheaper online. What you tend not to get with the cheapest online option is the in-person assessment and monitoring that comes as standard with every tier here. For a new medicine in particular, that care is the part worth paying for, and it is what we build our service around.
Safety and Side Effects
Like other GLP-1 medicines, the most common side effects of Foundayo are gastrointestinal: nausea, diarrhoea, constipation and indigestion. These are usually most noticeable early on or after a dose increase, and tend to settle as your body adjusts. Starting low and building up slowly, under the supervision of your prescriber, is designed to keep them to a minimum.
Foundayo is not suitable for everyone, including during pregnancy and breastfeeding. Your prescriber will go through your full medical history, the benefits and the risks, so you can make an informed decision, and will explain what to watch for and when to seek help before you start.
Already on Mounjaro or Wegovy?
If you are already doing well on an injection, there is usually no strong reason to change. But if you are curious about the pill, have struggled with the injections themselves, or have a specific reason to consider a move, it is a fair question to ask. We cover what the evidence actually shows about switching, including when staying put is the right call, in our guide to switching to Foundayo.
Why Choose Medihub for Foundayo
A new treatment is only as good as the clinician guiding you through it. At Medihub you are seen in person by a named Independent Prescriber, a pharmacist qualified to assess and prescribe in their own right. At Killay that is Osama Al-Saied, GPhC number 2222112, publicly verifiable on the pharmacy regulator’s register. At Pontarddulais you are seen by Carwyn Jones, also a GPhC-registered Independent Prescriber. With a drug this new, being able to sit down with someone who knows your history is worth a great deal.
Both branches offer the same service at the same standard. The Killay branch on Gower Road, SA2 7BA, serves Killay, Sketty, West Cross and the Gower peninsula. The Pontarddulais branch on St Teilo Street, SA4 8ST, is convenient for Pontarddulais, Gorseinon, Llansamlet and Morriston, and within easy reach of the wider Swansea area. We are also developing an ongoing membership-style support option for patients on longer-term weight management, with more to follow.
“Had an appointment with the prescribing chemist Osama, who was incredibly helpful and kind. Gave me all the information I needed in a way I could understand.”
Sophie H. — Google Review
Interested in Foundayo?
Book a weight management consultation at our Killay or Pontarddulais branch. Face-to-face assessment, no GP referral needed.
Frequently Asked Questions
What is Foundayo?
Foundayo is the brand name for orforglipron, a once-daily weight loss tablet from Eli Lilly. It is a GLP-1 medicine, like Mounjaro and Wegovy, but taken as a pill rather than an injection, and it was approved in the UK in August 2026 for weight management and type 2 diabetes.
How is Foundayo different from the Wegovy pill?
Both are tablets, but Foundayo can be taken at any time of day, with or without food or water. The Wegovy pill has to be taken on an empty stomach with a small sip of water and a wait before eating. Foundayo’s flexibility is its main practical advantage.
Is Foundayo available on the NHS?
Not currently. NICE is due to decide on 18 November 2026, and even a positive decision would likely mean phased, restricted access from 2027. For now it is available privately, which is what we offer at Medihub.
How much does Foundayo cost at Medihub?
Prices range from £109 for the starting dose up to £189 for the highest, per 30 tablets, and every tier includes your monthly face-to-face consultation, blood pressure check and weight check. Your prescriber confirms your price at your consultation.
Does Foundayo affect the contraceptive pill?
It can. Foundayo may slow stomach emptying, which can affect how well the oral contraceptive pill is absorbed, particularly while your dose is increasing. If you use the pill for contraception, tell your prescriber, as extra precautions may be advised.
Do I need a GP referral?
No. You can book a private weight management consultation directly with either Swansea branch, and our Independent Prescribers assess and prescribe without GP involvement.
Can I switch to Foundayo from Mounjaro or Wegovy?
It is possible, and it is a decision worth taking properly rather than on impulse. If you are doing well on your current treatment there is often no need to change. Our guide to switching to Foundayo covers what the evidence shows.
Foundayo is a real step forward for anyone who wanted the results of a GLP-1 treatment without the needle or the routine. If you would like to know whether it is right for you, book a consultation at your nearest Swansea branch, or read our complete guide to weight loss treatment in Swansea.
Reviewed and medically verified by
Osama Al-Saied, Independent Prescriber
GPhC Number: 2222112 | Independent Prescriber
Medihub Pharmacy, Killay and Pontarddulais, Swansea
Verify on the GPhC register
Last reviewed: 13 September 2026 · Medically reviewed ✓
